Addiction Psychiatrist, Lecturer, Monash University
Dr. Shalini Arunogiri is a consultant addiction psychiatrist at Turning Point (Eastern Health), and is a clinician, researcher and teacher.
She has extensive clinical experience in the addictions field and has worked as a clinician across both public and private mental health services and the drug and alcohol sector. She is an adjunct lecturer at Monash University, and is Chair of the Faculty of Addiction Psychiatry committee at the Royal Australian and New Zealand College of Psychiatrists (RANZCP). She has been an invited speaker at conferences on topics relating to substance use and mental health comorbidity, and regularly contributes to policy submission on this topic. Dr Arunogiri’s research interests include the neurobiological underpinnings of addictive disorders, the diagnosis and management of co-morbid mental health and substance use problems, and reform of the treatment system to provide best-practice evidence based integrated care for people with co-occurring disorders.
Nov 26, 2018 15:56 pm UTC| Health
Pregabalin (sold under the brand name Lyrica) is prescribed as an anti-epileptic and a painkiller for nerve pain. Australian prescriptions of pregabalin have risen significantly in the past five years. Its now in the top...